Jianzhong Shentu

Jianzhong Shentu

Auto-generated profile, based on publicly available information

Jianzhong Shentu

Research Center of Clinical Pharmacy, State Key Laboratory for Diagnosis and Treatment of Infectious Disease, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QZQiao Zhang
Qiao Zhang
YZYunliang Zheng
Yunliang Zheng
XHXingjiang Hu
Xingjiang Hu
XHXiaolong Hu
Xiaolong Hu
WLWenwen Lv
Wenwen Lv
JSJianzhong Shentu
Jianzhong Shentu

1 November 2012 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
JSJianzhong Shentu
Jianzhong Shentu
LFLizhi Fu
Lizhi Fu
HZHuili Zhou
Huili Zhou
XHXing Jiang Hu
Xing Jiang Hu
JLJian Liu
Jian Liu
GWGuolan Wu
Guolan Wu

8 March 2011 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
LWLin-Run Wang
Lin-Run Wang
GZGuo-Bing Zhang
Guo-Bing Zhang
JCJian Chen
Jian Chen
JLJun Li
Jun Li
MLMing-Wei Li
Ming-Wei Li
JTJian-Zhong Shen Tu
Jian-Zhong Shen Tu
To evaluate the predictive values of gene expressions of ribonucleotide reductase M1 (RRM1) and breast cancer susceptibility gene 1 (BRCA1) in peripheral blood from Chinese patients with non-small-cell lung cancer (NSCLC) treated with gemcitabine plus platinum. Forty Chinese patients with advanced NSCLC were recruited and received gemcitabine 1 200 mg/m2 on Days 1 and 8 plus carboplatin AUC 5 on Day 1. RRM1 and BRCA1 expression levels in peripheral blood were detected by quantitative reverse transcription-polymerase chain reaction (RT-PCR). Kaplan-Meier survival curve and log-rank test were performed to evaluate the correlation between gene expression and overall survival for these subjects. No correlation was observed between gene expression of RRM1 and that of BRCA1 (P>0.05), but there was a strong correlation between the expression of RRM1 and the response to chemotherapy (P=0.003). Subjects with low RRM1 expression levels in peripheral blood had longer survival time than those with high RRM1 expression levels (16.95 vs. 12.76 months, log-rank 3.989, P=0.046). However, no significant association between BRCA1 expression levels and survival time was found (16.80 vs. 13.77 months, log-rank 0.830, P=0.362). Patients with low RRM1 expression levels in peripheral blood have a greater response to chemotherapy and longer survival time. Advanced NSCLC patients with low RRM1 expression levels may benefit from gemcitabine plus platinum therapy. RRM1 mRNA expression in peripheral blood could be used to predict the prognosis of NSCLC treated by gemcitabine and platinum.

1 February 2008 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
MHMing-Zhu Huang
Ming-Zhu Huang
JSJian-Zhong Shentu
Jian-Zhong Shentu
JCJun-Chun Chen
Jun-Chun Chen
JLJian Liu
Jian Liu
HZHui-Li Zhou
Hui-Li Zhou
This study presents a rapid, specific and sensitive liquid chromatography/tandem mass spectrometry (LC-MS/MS) assay for determination of risperidone (RIS) in human serum using paroxetine as an internal standard (IS). An Alltima-C18 column (2.1 mm×100 mm, 3 μm) and a mobile phase consisting of 0.1% formic acid-acetonitrile (40:60, v/v) were used for separation. The analysis was performed by selected reaction monitoring (SRM) method, and the peak area of the m/z 411.3→191.1 transition for RIS was measured versus that of the m/z 330.1→192.1 transition for IS to generate the standard curves. The assay linearity of RIS was confirmed over the range 0.25∼50.00 ng/ml and the limit of quantitation was 0.05 ng/ml. The linear range corresponds well with the serum concentrations of the analytes obtained in clinical pharmacokinetic studies. Intraday and interday relative standard deviations were 1.85%∼9.09% and 1.56%∼4.38%, respectively. The recovery of RIS from serum was in the range of 70.20%∼84.50%. The method was successfully applied to investigate the bioequivalence between two kinds of tablets (test versus reference products) in 18 healthy male Chinese volunteers. The result suggests that two formulations are bioequivalent.

31 July 2009 in Clinical Therapeutics
Verified
Journal Article
Closed access
LFLimin Feng
Limin Feng
JSJianzhong Shen-Tu
Jianzhong Shen-Tu
JLJian Liu
Jian Liu
JCJunchun Chen
Junchun Chen
LWLihua Wu
Lihua Wu
MHMingzhu Huang
Mingzhu Huang

3 May 2012 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
JLJian Liu
Jian Liu
JSJian-Zhong Shentu
Jian-Zhong Shentu
LWLi-Hua Wu
Li-Hua Wu
JDJing Dou
Jing Dou
QXQi-Yang Xu
Qi-Yang Xu
JCJun-Chun Chen
Jun-Chun Chen
In order to comply with the requirements for a drug listed in China, the study was developed to compare the pharmacokinetics and relative bioavailability of two different enteric formulations of omeprazole (OPZ) in healthy Chinese subjects. A total of 32 volunteers participated in the study. Plasma concentrations were analyzed by nonstereospecific liquid chromatography/tandem mass spectrometric (LC-MS/MS) method. After administration of a single 40-mg dose of the two OPZ formulations, the comparative bioavailability was assessed by calculating individual AUC0−t (the area under the concentration-time curve from time zero to the last measurable concentration), AUC0−∞ (the area under the concentration-time curve extrapolated to infinity), C max (the maximum observed concentration), and T peak (the time to C max) values of OPZ, 5-hydroxyomeprazole (OH-OPZ), and omeprazole sulfone (OPZ-SFN), respectively. The 90% confidence intervals (CIs) of AUC0−t , AUC0−∞, and C max were 85.4%–99.0%/88.8%–98.6%/87.6%–99.4%, 85.5%–99.2%/89.0%–98.6%/88.5%–101.3%, and 72.3%–87.6%/79.6%–91.1%/88.4%–99.1% for OPZ/OH-OPZ/OPZ-SFN, respectively, and T peak values did not differ significantly. In this study, the test formulation of OPZ in fasting healthy Chinese male volunteers met the Chinese bioequivalance standard to the reference formulation based on AUC, C max, and T peak.